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1. Introduction 2. Materials and methods 
Alkylating antitumor agents are known to cause a 
rapid decrease in the incorporation of labeled thymi- 
dine into the DNA of tumor cells (Wheeler [1,2]). 
This effect has been interpreted as an inhibition of 
DNA synthesis by the alkylating agent. However, we 
have been able to demonstrate hat despite the inhibi- 
tion of the incorporation of labeled thymidine into 
DNA, the rate of DNA synthesis remains unaltered 
after administration of 6 X 10 -7 moles/kg of triethyl- 
eneiminobenzoquinone (Trenimon) [3]. Considering 
the tight coupling of DNA and histone synthesis [4-  
7] one should expect he incorporation of labeled pre- 
cursors into histones to be unaffected under condi- 
tions where DNA synthesis proceeds normally. Busch 
et al. [8, 9] have reported that the biosynthesis of the 
histones is relatively resistant to aminouracil mustard. 
According to their studies the synthesis of the non- 
histone proteins is most sensitive to alkylating agents. 
A high sensitivity of the non-histone nuclear proteins 
to alkylating agents has also been described by Nyhan 
[10]. The present studies demonstrate hat - con- 
trary to all expectations - concentrations of the alky- 
lating agent Trenimon which do not affect the biosyn- 
thesis of DNA in Ehrlich ascites cells strongly inhibit 
the incorporation of [3H]lysine into histones whereas 
[3H]lysine incorporation i to the chromosomal non- 
histone proteins and the total cellular proteins is hard- 
ly affected. 
2, 3, 5-Triethyleneiminobenzoquinone (Trenimon) 
was donated by Farbenfabriken Bayer AG, Leverkusen, 
Germany. 4, 5-[3H]lysine (250 Ci/mol) was obtained 
from the Radiochemical Centre, Amersham, England. 
Ehrlich ascites tumor cells were grown and harvested 
5 -6  days after transplantation as described previous- 
ly [11]. 
The preparation of nuclear proteins was performed 
as described elsewhere [12] with the exception that 
the acid soluble nuclear proteins were extracted im- 
mediately after the washings with 0.14 M NaC1-0.01 
M sodium citrate. The extraction with 2 M NaC1 was 
omitted. Determination of the total cellular protein 
was performed by precipitating an aliquot of a sus- 
pension of Ehrlich ascites cells by addition of HC10 4 
to a final concentration of 0.7 N. The precipitate was 
washed once with 0.2 N HC10 4 and solubilized in 
0.1 N NaOH. 
Protein determinations were performed according 
to Lowry et al. [13] with bovine albumin as a stan- 
dard. The radioactivity of the solubilized protein frac- 
tions was determined in a scintillation spectrophoto- 
meter by pipetting an aliquot of the protein solution 
into the scintillation fluid described previously [12]. 
Gel electrophoresis was performed by a modification 
of the procedure described by Bonner et al. [14]. 
The modification consisted in replacing the N, N- 
methylene-bis-acrylamide by ethylene diacrylate. The 
use of the latter renders the gels soluble in 1 N 
NH4OH and 'Nuclear Chicago Solubilizer' (NCS) 
[15]. The gels were stained with Amido Black 10 B 
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Fig. t. Effect of triethyleneiminobenzoquinone (Trenimon) on the incorporation of [3H]lysine into proteins of Ehrlich ascites 
tumor cells: (o - -o- -o)  Total cellular protein; (× - -×  - -×)  nuclear non-historic proteins; ( , - - , - -e )  acid soluble nuclear pro- 
teins. Tumor bearing animals received various concentrations ofTrenimon in 0.14 M NaC1 i.p. Controls received NaC1 only. Four 
hours later each animal was injected i.p. with 30 uCi of [3H]lysine. After an additional hour, the tumors were harvested. Prepara- 
tion and determination of the protein fractions are described under Materials and methods. For each determination, pooled tu- 
mors from 4 animals were employed. 
and destained electrophoretically. The protein con- 
tent of the stained proteins on the gel was determined 
densitometrically. The gels were scanned with a 
Gflford photometer equipped with a densitometer at- 
tachment and the areas of the tracings were measured 
with a planimeter. In a range between 5 and 50/ag of 
protein, a linear relationship was obtained between 
the amount of protein applied to the gel and the val- 
ues obtained ensitometrically. For the determination 
of the radioactivity, the individual bands were cut out 
with a razor blade. The gel slices were solubflized over- 
night in 1 N NI-I4OH and NCS as described by Cain 
and Pitney [15] and after addition of  I0 ml of scintfl. 
later [15] the radioactivity was measured in a scintil- 
lation spectrophotometer. DNA was determined ac- 
cording to Keck [16] with calf thymus DNA as a 
standard. 
3. Results 
Fig. 1 shows the effect of  various doses of 
Trenimon on the incorporation of [3H]lysine into 
the acid soluble nuclear proteins, the nuclear non.his- 
tone proteins and the total proteins of Ehrlich ascites 
tumor cells. There is a strong dose dependent de- 
crease in the incorporation of the labeled lysine into 
the acid soluble nuclear proteins whereas the labeling 
of the total cellular proteins and the nuclear non-his- 
tone proteins is much less affected. Gel electrophoret- 
ic separation of the acid soluble proteins obtained 4
hr after treatment with the drug showed no signifi- 
cant changes in the relative or absolute amounts of 
the different histone fractions and revealed that the 
four histone fractions which are separated on the gel 
are affected to about the same extent (fig. 2, table 1). 
The slightly smaller inhibition of  the lysine incorpora- 
tion into the FI-fraction may be due to contaminating 
non-histone proteins. The time course of  the effect of 
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Fig. 2. Densitometer scans of polyacrylamide gel electropho- 
reses of acid soluble nuclear proteins from Ehrlich ascites tu- 
mor cells: a) control; b) material obtained 4 hr after treat- 
ment of tumor bearing mice with 6 X 10 -7 moles/kg 
Trenimon. The vertical lines underneath t e abscissa indicate 
the positions where the gel s have been cut for radioactivity 
determinations. The gel slices were designated by Roman nu- 
merals corresponding to the migration of the individual his- 
tone fractions. Histones lla and l ib are not separated on this 
gel and represent fraction II. For experimental details ee 
Materials and methods. 
a single dose of  the alkylat ing agent (6 × 10 -7  moles/  
kg) on the incorporat ion  rate o f  lysine into the acid 
soluble nuclear prote ins reaches a min imum 4 hr after 
administ rat ion of  the drug. A l though there is a slight 
decrease in the inh ib i tory  effect dur ing the subsequent  
20 hr the marked depression of  the labeling of  the 
acid soluble nuclear prote ins can still be observed 24 hr  
after exposure to the alkylat ing agent. Table 2 demon-  
strates that  despite the marked inh ib i t ion of  the incor- 
porat ion of  labeled lysine into the acid soluble nuclear 
proteins,  the amount  of DNA which is synthesized ur- 
ing the 24 hr- interval  fol lowing the admin is t rat ion of  
Table 1 
Effect of triethyleneiminobenzoquinone (Trenimon) on the 
incorporation of [ 3 H ]ly sine into the histones of Ehrlich 
ascites tumor cells. 
Fraction Control + Trenimon % of the control 
dpm/t~g dpm/gg 
I 408 ± 60.3 146 ± 29.3 35.8 
IIl 404 ± 14.8 108 ± 3.6 26.7 
II 196 ± 5.8 53+- 1.8 27.0 
IV 144 ± 13.3 44 ± 5.0 30.6 
4 Tumor bearing mice received 3 × 10 -7 moles/kg Trenimon 
i.p. After 4 hr 100 gCi of [3H]lysine was injected i.p. into 
each Trenimon-treated animal and into 4 untreated mice 
which served as controls. One hour later the animals were 
killed. The tumors of each group (the Trenimon-treated group 
and the control group) were pooled and the acid soluble nu- 
clear proteins were prepared as described under Materials and 
methods. The histone fractions were prepared and analyzed as 
described in the legend to fig. 2. The values represent the 
means of 5 determinations ± .d. 
Table 2 
Effect of triethyleneiminobenzoquinone (Trenimon) on DNA 
synthesis and cell multiplication of Ehrlich ascites tumor cells. 
Time : 0 Time : 24 hr 
Controls + Trenimon 
Tumor cells/animal 4.3 ± 0.3 7.1 ± 0.2 3.9 ± 0.1 
(X 10 -s) 
Tumor DNA/animal 6.6 ± 0.4 10.1 ± 0.3 9.2 ± 0.6 
(mgh 
DNA/tumor cell 15.5 ± 0.6 14.1 ± 0.7 21.3 ± 1.4 
(Pg) 
Treminon (6 X 10 -7 moles/kg) was injected i.p, into tumor 
bearing mice 5 days after transplantation f the tumor. Con- 
troi animals received the corresponding volume (0.2 ml) of 
0.14 M NaCI. Immediately following the injection, ten of the 
control animals were killed and the tumor cells collected from 
each individual animal. After 24 hr another ten of the 
Trenimon-treated and another ten of the control animals 
were killed. Care was taken to collect the tumor cells quanti- 
tatively from each individual animal by excessive rinsing of 
the peritoneal cavity and the intestine with 0.25 M sucrose. 
Cell counts were performed microscopically with the aid of 
a Neubauer counting chamber. DNA was determined accord- 
ing to Keck [ 16]. The values represent means of 10 deter- 
minations ±s.d. 
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Fig. 3. Effect of triethyleneiminobenzoquinone (Trenimon) on the incorporation of [ 3H]lysine into proteins of Ehrlich ascites tu- 
mor cells as a function of time after exposure to the drug. Tumor bearing mice received 6 × 10 -7 moles/kg Trenimon in 0.14 M 
NaCI i.p. Control animals received NaCI only. One hour before harvesting the tumors, each animal was injected with 40 ~tCi of 
[aH]lysine. Groups of 4 animals were killed at the time points indicated, the tumors pooled and the protein fractions isolated as 
described under Materials and methods. 
6 × 10 -7 moles/kg Trenimon is about the same in 
Trenimon-treated as well as in untreated populations 
of Ehrlich ascites cells. 
4. Discussion 
Busch et al. [8, 9] have reported that aminouracil 
mustard ecreases the rate of labeling of the non-his- 
tone nuclear proteins at earlier times and at lower 
doses of the drug than the labeling of histones or cy- 
toplasmic proteins. Further studies with various alky- 
lating agents have lead to the conclusion that the sup- 
pression of labeling of  the non-histone nuclear pro- 
teins (called acidic proteins by these authors) is the 
only constant feature of the effects of antitumor 
agents on protein labeling [17]. The data shown in 
this paper demonstrate hat this statement cannot be 
generalized. Our results show that all concentrations 
of the ethyleneimino compound used and at all time 
points studied, the incorporation of [3H]lysine into 
the acid soluble nuclear proteins was suppressed to a 
much greater extent than the labeling of the non-his- 
tone nuclear proteins or the total cellular proteins. 
Although the acid soluble nuclear proteins contain 
some other proteins besides histones, the extent of 
the inhibitory effects observed as well as the data 
shown in table 1 permit the conclusion that the de- 
crease in the labeling of the acid soluble nuclear pro- 
rein is due to an inhibition of the incorporation of 
the [3H]lysine into the histones. At a Trenimon dose 
of 6 × 10 -7 moles/kg - which as shown in table 2 
completely blocks cell multiplication - the labeling 
of the non-histone protein is hardly affected whereas 
the [3H]lysine incorporation i to the nuclear histones 
is markedly suppressed (fig. 1). The decrease in the 
incorporation of labeled lysine into the nuclear histones 
lasts for at least 24 hr after a single dose of the alky- 
lating agent. However, despite the decreased labeling 
of the histones, the net increase in the amount of  the 
DNA determined 24 hr after injection of 6 × 10 -7 
moles/kg Trenimon is about the same as in untreated 
controls. This is in accordance with previous findings 
from our laboratory which demonstrate hat this 
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Trenimon concentration - although it decreases the 
incorporation of  labeled thymidine into the DNA - 
does not affect the synthesis of DNA during the first 
24 hr following the injection of the drug [3]. This 
was also found to be the case during the first 8 hr-in- 
terval after administration of the drug, a time period 
in which the suppression of histone labeling is at its 
maximum [3]. 
The data demonstrate hat the alkylating agent is 
capable of dissociating the synthesis of DNA and the 
increase in the amount of the histones in the cell nu- 
cleus, two processes which are normally tightly coor- 
dinated. The reason why this effect has not been ob- 
served so far is probably due to the fact that most in- 
vestigators used the incorporation of labeled thymi- 
dine into DNA as a measure for DNA synthesis. As men- 
tioned above, this procedure can be misleading. The 
same discrepancy between thymidine incorporation 
and DNA synthesis has been described as occurring 
after X-irradiation [18]. The differential effects on 
thymidine incorporation and DNA synthesis may be 
due to alterations in pool sizes of the thymidine nu- 
cleotides [19]. The prevailing inhibition of the incor- 
poration of [3H]lysine into the histones, however, 
cannot be explained by changes in the intracellular ly- 
sine pool or an impairment of the lysine transport into 
the cell as both mechanisms would equally affect the 
non-histone proteins and the majority of the total cel- 
lular proteins. Our data do not permit a decision on 
whether the suppression of the histone labeling is 
caused by an inhibition of histone synthesis or by a 
block in the transport of the preformed histones from 
the cytoplasm into the nucleus. However, the latter 
possibility seems unlikely as the transport of the non- 
histone proteins - of which the majority is also syn- 
thesized in the cytoplasm [20] - is obviously not af- 
fected. 
During the preparation of this manuscript a publi- 
cation by Riches and Harrap appeared on the effects 
of chlorambucil on the chromatin of  Yoshida ascites 
cells [21]. Their results are very similar to our find- 
ings with Trenimon by Ehrlich ascites cells. According 
to Riches and Harrap chlorambucil does not affect the 
synthesis of DNA during the first 24 hr after treat- 
ment, but leads to a progressive decrease in the his- 
tone/DNA ratio. 
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